BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

340 related articles for article (PubMed ID: 16267496)

  • 1. Incidence of end-stage renal disease among persons with diabetes--United States, 1990-2002.
    Centers for Disease Control and Prevention (CDC)
    MMWR Morb Mortal Wkly Rep; 2005 Nov; 54(43):1097-100. PubMed ID: 16267496
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Racial differences in trends of end-stage renal disease, by primary diagnosis--United States, 1994-2004.
    Centers for Disease Control and Prevention (CDC)
    MMWR Morb Mortal Wkly Rep; 2007 Mar; 56(11):253-6. PubMed ID: 17380108
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Incidence of end-stage renal disease attributed to diabetes among persons with diagnosed diabetes --- United States and Puerto Rico, 1996-2007.
    Centers for Disease Control and Prevention (CDC)
    MMWR Morb Mortal Wkly Rep; 2010 Oct; 59(42):1361-6. PubMed ID: 21030940
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Disproportionately high incidence of diabetes-related end-stage renal disease in the Canary Islands. An analysis based on estimated population at risk.
    Lorenzo V; Boronat M; Saavedra P; Rufino M; Maceira B; Novoa FJ; Torres A
    Nephrol Dial Transplant; 2010 Jul; 25(7):2283-8. PubMed ID: 20064954
    [TBL] [Abstract][Full Text] [Related]  

  • 5. State-specific trends in chronic kidney failure--United States, 1990-2001.
    Centers for Disease Control and Prevention (CDC)
    MMWR Morb Mortal Wkly Rep; 2004 Oct; 53(39):918-20. PubMed ID: 15470324
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Geographic, ethnic, age-related and temporal variation in the incidence of end-stage renal disease in Europe, Canada and the Asia-Pacific region, 1998-2002.
    ; Stewart JH; McCredie MR; Williams SM
    Nephrol Dial Transplant; 2006 Aug; 21(8):2178-83. PubMed ID: 16595584
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Diabetic CKD/ESRD 2010: a progress report?
    Williams ME
    Semin Dial; 2010; 23(2):129-33. PubMed ID: 20210917
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Divergent trends in the incidence of end-stage renal disease due to Type 1 and Type 2 diabetes in Europe, Canada and Australia during 1998-2002.
    ; Stewart JH; McCredie MR; Williams SM
    Diabet Med; 2006 Dec; 23(12):1364-9. PubMed ID: 17116189
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hospitalization discharge diagnoses for kidney disease--United States, 1980-2005.
    Centers for Disease Control and Prevention (CDC)
    MMWR Morb Mortal Wkly Rep; 2008 Mar; 57(12):309-12. PubMed ID: 18368005
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Time trends in the epidemiology of renal transplant patients with type 1 diabetes mellitus over the last four decades.
    Cao C; Hellermann JP; Weber M; Ambühl PM
    Nephrol Dial Transplant; 2006 Mar; 21(3):770-5. PubMed ID: 16401627
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Optimizing end-stage renal disease therapy for the patient with diabetes mellitus.
    Friedlander MA; Hricik DE
    Semin Nephrol; 1997 Jul; 17(4):331-45. PubMed ID: 9241718
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Trends in incidence of treated end-stage renal disease, overall and by primary renal disease, in persons aged 20-64 years in Europe, Canada and the Asia-Pacific region, 1998-2002.
    Stewart JH; McCredie MR; Williams SM; Jager KJ; Trpeski L; McDonald SP;
    Nephrology (Carlton); 2007 Oct; 12(5):520-7. PubMed ID: 17803478
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Incidence trends and mortality in end-stage renal disease attributed to renovascular disease in the United States.
    Fatica RA; Port FK; Young EW
    Am J Kidney Dis; 2001 Jun; 37(6):1184-90. PubMed ID: 11382687
    [TBL] [Abstract][Full Text] [Related]  

  • 14. End-stage renal disease due to diabetes in racial/ethnic minorities and disadvantaged populations.
    Lopes AA
    Ethn Dis; 2009; 19(1 Suppl 1):S1-47-51. PubMed ID: 19484875
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Exploring secular trends in the likelihood of receiving treatment for end-stage renal disease.
    Hsu CY; Go AS; McCulloch CE; Darbinian J; Iribarren C
    Clin J Am Soc Nephrol; 2007 Jan; 2(1):81-8. PubMed ID: 17699391
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prevalence of self-reported cardiovascular disease among persons aged > or =35 years with diabetes--United States, 1997-2005.
    Centers for Disease Control and Prevention (CDC)
    MMWR Morb Mortal Wkly Rep; 2007 Nov; 56(43):1129-32. PubMed ID: 17975525
    [TBL] [Abstract][Full Text] [Related]  

  • 17. End-stage renal disease: magnitude of the problem, prognosis of future trends and possible solutions.
    Port FK
    Kidney Int Suppl; 1995 Aug; 50():S3-6. PubMed ID: 8544432
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Trends in incidence of end-stage renal disease in Japan, 1983-2000: age-adjusted and age-specific rates by gender and cause.
    Wakai K; Nakai S; Kikuchi K; Iseki K; Miwa N; Masakane I; Wada A; Shinzato T; Nagura Y; Akiba T
    Nephrol Dial Transplant; 2004 Aug; 19(8):2044-52. PubMed ID: 15173379
    [TBL] [Abstract][Full Text] [Related]  

  • 19. An improved understanding of the causes of end-stage renal disease.
    Young EW
    Semin Nephrol; 1997 May; 17(3):170-5. PubMed ID: 9165646
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Diabetic renal failure in Texas: influence of ethnicity and household income.
    Pazmiño PA; Pazmiño AK
    Tex Med; 2003 Oct; 99(10):57-65. PubMed ID: 14650814
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.